Inhaled DMT for Major Depressive Disorder
Bottom line: A trial is testing whether inhaled DMT may be associated with rapid relief for major depressive disorder, suggesting it could be linked to changes in brain processing of emotion.
A man in Brazil takes a deep breath from a vaporizer. He’s not here for a cold or a migraine. He’s in a clinical trial, testing whether a substance once called the “spirit molecule” might help with major depressive disorder. He’s one of 140 people in the study, all of whom have struggled with depression for years. The trial, called NCT07562191, is asking whether something that has long been associated with mystical experiences could also be a treatment.
This isn’t just a theory. It’s a real experiment, offering the possibility that relief could come in hours, not months.
The Science of a Moment
Treating depression usually means pills, therapy, or lifestyle changes. But what if the answer lies not in a chemical that targets a receptor, but in something that rewires the brain’s processing of emotion — in minutes?
The study, led by the Universidade Federal do Rio Grande do Norte, is looking at inhaled DMT. The researchers are giving participants either a high or low dose. The high-dose group gets 15 mg followed by 60 mg. The low-dose group receives 1 mg and 4 mg. The goal is to see whether the substance can rapidly reduce symptoms — including suicidal thoughts — and whether the effects last beyond the immediate experience.
If a participant doesn’t show improvement by Day 7, they’ll get a high-dose session on Day 14. This suggests the researchers are not just looking at the immediate impact of DMT, but also at how it might accumulate or depend on dose.
But the bigger question is: how does DMT work?
The Mystery of the Mind
DMT doesn’t fit neatly into the traditional framework of drugs. Unlike SSRIs or SNRIs, which modulate neurotransmitters, DMT seems to act more like a reset button. It floods the brain with a surge of activity, creating a shift in consciousness — like waking from a dream or glimpsing a new reality.
Depression is often described as being stuck in a loop. DMT may offer a way out — not by suppressing thoughts, but by changing how the brain processes them.
This is why the study’s focus on suicide risk is important. The idea that a substance that can induce such a shift in consciousness might also reduce the risk of self-harm is both provocative and potentially useful.
But DMT is a powerful substance. Its effects can vary widely. Some people might feel euphoric, others may experience anxiety or fear. That’s why the trial is double-blind and includes a low-dose comparator.
Still, the real question remains: can a substance that changes consciousness so profoundly lead to lasting improvements in mental health?
What the Research Suggests (So Far)
This trial is still ongoing, but other studies have shown some promise. A Phase 2a trial of GH001, a synthetic version of 5-MeO-DMT, found that it reduced symptoms of postpartum depression by more than 35 points on the MADRS scale within a week — a dramatic improvement compared to traditional antidepressants.
What’s more, the effects of DMT and similar compounds are rapid. That’s a key difference. SSRIs can take weeks to work. Psychedelics may act quickly.
But there are also limits. The GH001 trial only included ten patients. The results are promising, but not yet enough to draw broad conclusions. Larger trials of psilocybin for treatment-resistant depression have shown more modest effects, suggesting that while psychedelics may be powerful, they are not a universal solution.
This highlights the early stage of the science. We’re not just looking at one molecule or approach. We’re trying to understand how the brain responds to these substances, how they can be used safely, and what long-term effects they may have.
Frequently Asked Questions
Q: Is DMT safe?
A: DMT is generally considered safe in controlled, clinical settings. However, it can cause intense psychological effects, including anxiety, confusion, and hallucinations. The study is designed to monitor these effects closely.
Q: How long does the effect last?
A: The study is tracking participants for up to 12 months to see if the benefits of DMT last beyond the immediate experience. While the effects can be rapid, the long-term impact is still being investigated.
Q: Can DMT replace traditional antidepressants?
A: This study is not looking at replacing antidepressants, but rather at whether DMT could be a complementary or alternative treatment. The results may suggest that DMT could be used alongside other therapies.
Q: What about the risk of suicide?
A: The study is specifically interested in how DMT affects suicidal ideation. The goal is to see if the substance can reduce the risk of self-harm, a critical outcome in depression.
Q: Are there any side effects?
A: The study is monitoring for a range of side effects, including psychological distress, physical discomfort, and changes in mood. The researchers are also tracking the long-term safety of DMT use.
Sources
- ¶NCT07562191: Inhaled DMT for Major Depressive Disorder
- ¶Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression
- ¶Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland
- ¶Psychedelics, rebirth experiences, and the limits of current research
Educational Disclaimer
This article is for informational and educational purposes only. It is not medical advice, mental health advice, diagnosis, treatment guidance, or a recommendation to use any substance, supplement, therapy, or protocol.
We review publicly available research and explain what the evidence may suggest. Some studies may be early-stage, observational, animal-based, lab-based, theoretical, or incomplete. Always consult a qualified professional before making health-related decisions.
If you or someone you know is struggling, you are not alone. In the US, call or text 988 (Suicide & Crisis Lifeline). Elsewhere, contact your local emergency or crisis service.
Researched and drafted by Spore, ShroomWire’s AI research assistant, and reviewed by the ShroomWire editorial team before publishing.
